Smith & Nephew (SNNUF) Shares Outstanding (Weighted Average) (2009 - 2025)

Smith & Nephew (SNNUF) reported Shares Outstanding (Weighted Average) of $175.0 million for Q4 2025, little changed on a YoY basis from $175.0 million in Q4 2024, and little changed quarter-over-quarter from $175.0 million in Q2 2025.

Smith & Nephew (SNNUF) Shares Outstanding (Weighted Average) (2009 - 2025) Analysis & Trends

Smith & Nephew has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $175.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $175.0 million; the trailing twelve-month figure through Dec 2025 stood at $175.0 million (changed 0.0% YoY), and the FY2025 full-year result was $175.0 million, changed 0.0% from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 stood at $175.0 million, roughly flat from $175.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $872.0 million in Q4 2022, with the low at $175.0 million in Q2 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $374.3 million across 5 years, with a median of $175.0 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) jumped 392.66% — and 2024, when it sank 79.91%.
  • Smith & Nephew's Shares Outstanding (Weighted Average) stood at $177.0 million in 2021, then soared by 392.66% to $872.0 million in 2022, then decreased by 0.11% to $871.0 million in 2023, then slumped by 79.91% to $175.0 million in 2024, then changed by 0.0% to $175.0 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $175.0 million (Q4 2025), $175.0 million (Q2 2025), and $175.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.74 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 382.90 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 456.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 98.20 Mn
10 Smith & Nephew - - - 175.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 175.00 Mn
Jun 28, 2025 175.00 Mn
Dec 31, 2024 175.00 Mn
Jun 29, 2024 175.00 Mn
Dec 31, 2023 871.00 Mn
Dec 31, 2022 872.00 Mn
Dec 31, 2021 177.00 Mn
Dec 31, 2020 177.00 Mn
Jun 30, 2020 177.00 Mn
Dec 31, 2019 177.00 Mn
Jun 29, 2019 177.00 Mn
Dec 31, 2018 873.00 Mn
Jun 30, 2018 178.00 Mn
Dec 31, 2017 874.00 Mn
Dec 31, 2016 890.00 Mn
Dec 31, 2015 894.00 Mn
Jun 30, 2015 183.00 Mn
Dec 31, 2014 56.10 Mn
Sep 30, 2014 184.00 Mn
Jun 28, 2014 184.00 Mn